Feng Xu

机构：ES Technology (United Kingdom), Second Affiliated Hospital of Jilin University, Jinzhou Medical University · ORCID：0000-0003-3123-6107

发表论文 44 篇 · 总被引 1297 次 · h-index 22

代表论文

• LncRNA PVT1 regulates ferroptosis through miR-214-mediated TFR1 and p53 (2020 · Life Sciences · 被引 296)
• RETRACTED: Sinomenine inhibits proliferation, migration, invasion and promotes apoptosis of prostate cancer cells by regulation of miR-23a (2019 · Biomedicine & Pharmacotherapy · 被引 83)
• Functions of RNA N6-methyladenosine modification in cancer progression (2019 · Molecular Biology Reports · 被引 67)
• Disposable Peptidoglycan-Specific Biosensor for Noninvasive Real-Time Detection of Broad-Spectrum Gram-Positive Bacteria in Exhaled Breath Condensates (2024 · Analytical Chemistry · 被引 48)
• miR-206 inhibits liver cancer stem cell expansion by regulating EGFR expression (2020 · Cell Cycle · 被引 44)
• Novel insights into the role of Clostridium novyi‑NT related combination bacteriolytic therapy in solid tumors (Review) (2020 · Oncology Letters · 被引 40)